US Patent 11629193 EGFR binding molecules
Patent 11629193 was granted and assigned to F-star on April, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 2 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 14 Aug, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Haijun Sun0
Kin-Mei Leung0
Melanie Medcalf0
Mihriban Tuna0
Samine Isaac0
Edits on 19 Apr, 2023
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+399 characters)
US Patent 11629193 EGFR binding molecules
Article
The application relates to specific binding members which bind the human epidermal growth factor receptor (EGFR). The specific binding members preferably comprise an EGFR antigen-binding site which may be located in two or more structural loops of a CH3 domain of the specific binding member. The specific binding members are expected to find application in the treatment of cancers expressing EGFR.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
116291930
Date of Patent
April 18, 2023
0Patent Application Number
163192350
Date Filed
July 19, 2017
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11629193 EGFR binding molecules
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
